Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@MasatoMurakami5 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1524588262035456000.png) @MasatoMurakami5 MasatoMurakami

MasatoMurakami posts on X about $4587t, barcelona, team and the most. They currently have XX followers and X posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::1524588262035456000/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1524588262035456000/c:line/m:interactions.svg)

- X Week XXX -XXXX%
- X Month XXX +399%
- X Months XXXXX +523%

### Mentions: X [#](/creator/twitter::1524588262035456000/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1524588262035456000/c:line/m:posts_active.svg)

- X Week X +14%
- X Month X +50%
- X Months XX +233%

### Followers: XX [#](/creator/twitter::1524588262035456000/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1524588262035456000/c:line/m:followers.svg)

- X Week XX +8.50%
- X Month XX +38%
- X Months XX +96%

### CreatorRank: undefined [#](/creator/twitter::1524588262035456000/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1524588262035456000/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1524588262035456000/influence)
---

**Social category influence**
[travel destinations](/list/travel-destinations)  XXXXX%

**Social topic influence**
[$4587t](/topic/$4587t) #2, [barcelona](/topic/barcelona) 22.22%, [team and](/topic/team-and) XXXXX%
### Top Social Posts [#](/creator/twitter::1524588262035456000/posts)
---
Top posts by engagements in the last XX hours

"Presentation update Spoke at the 17th Open Imaging Conference in Tsukuba under the chairmanship of Dr. Nakajima. Shared our vision for how theranostics is transforming cancer carefrom imaging to healing. #PeptiDream #PDRadiopharma #Theranostics #NuclearMedicine"  
[X Link](https://x.com/MasatoMurakami5/status/1945987535064190998) [@MasatoMurakami5](/creator/x/MasatoMurakami5) 2025-07-17T23:22Z XX followers, XXX engagements


"PeptiDreams Sustainability Impact Report 2025 is now available A clear commitment to mission-driven value creation and ESG across the Group. Proud to be part of this journey at PDRadiopharma. 📄 #Sustainability #ESG #PeptiDream #PDRPharma #MissionDriven"  
[X Link](https://x.com/MasatoMurakami5/status/1967721636301508724) [@MasatoMurakami5](/creator/x/MasatoMurakami5) 2025-09-15T22:46Z XX followers, XX engagements


"Our peptide-based theranostic programs PD-32766 (CA9) and PD-29875 (Claudin18.2) will be presented at #JCA2025. Proud to share this milestone from the PeptiDream / PDRadiopharma team. #Radiopharmaceuticals #PeptideDiscovery #OncologyInnovation"  
[X Link](https://x.com/MasatoMurakami5/status/1968167874448724423) [@MasatoMurakami5](/creator/x/MasatoMurakami5) 2025-09-17T04:19Z XX followers, XXX engagements


"📢 At #EANM2025 in Barcelona we will present results on PeptiDreams CA9-targeted peptide: 🔹 Preclinical data 🔹 First-in-human imaging data A milestone in peptide-based theranostics. #Radiopharma #Theranostics #CA9 #PDRPharma #PeptiDream"  
[X Link](https://x.com/MasatoMurakami5/status/1973858032242364809) [@MasatoMurakami5](/creator/x/MasatoMurakami5) 2025-10-02T21:10Z XX followers, XXX engagements


"🎯 Presentations from PeptiDream / PDRadiopharma at #EANM2025 in Barcelona successfully concluded We shared results from our CA9-targeted theranostic peptide program including first-in-human imaging data. Proud of our team and this exciting step forward in nuclear medicine"  
[X Link](https://x.com/MasatoMurakami5/status/1975053901650157904) [@MasatoMurakami5](/creator/x/MasatoMurakami5) 2025-10-06T04:21Z XX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@MasatoMurakami5 Avatar @MasatoMurakami5 MasatoMurakami

MasatoMurakami posts on X about $4587t, barcelona, team and the most. They currently have XX followers and X posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

  • X Week XXX -XXXX%
  • X Month XXX +399%
  • X Months XXXXX +523%

Mentions: X #

Mentions Line Chart

  • X Week X +14%
  • X Month X +50%
  • X Months XX +233%

Followers: XX #

Followers Line Chart

  • X Week XX +8.50%
  • X Month XX +38%
  • X Months XX +96%

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence #


Social category influence travel destinations XXXXX%

Social topic influence $4587t #2, barcelona 22.22%, team and XXXXX%

Top Social Posts #


Top posts by engagements in the last XX hours

"Presentation update Spoke at the 17th Open Imaging Conference in Tsukuba under the chairmanship of Dr. Nakajima. Shared our vision for how theranostics is transforming cancer carefrom imaging to healing. #PeptiDream #PDRadiopharma #Theranostics #NuclearMedicine"
X Link @MasatoMurakami5 2025-07-17T23:22Z XX followers, XXX engagements

"PeptiDreams Sustainability Impact Report 2025 is now available A clear commitment to mission-driven value creation and ESG across the Group. Proud to be part of this journey at PDRadiopharma. 📄 #Sustainability #ESG #PeptiDream #PDRPharma #MissionDriven"
X Link @MasatoMurakami5 2025-09-15T22:46Z XX followers, XX engagements

"Our peptide-based theranostic programs PD-32766 (CA9) and PD-29875 (Claudin18.2) will be presented at #JCA2025. Proud to share this milestone from the PeptiDream / PDRadiopharma team. #Radiopharmaceuticals #PeptideDiscovery #OncologyInnovation"
X Link @MasatoMurakami5 2025-09-17T04:19Z XX followers, XXX engagements

"📢 At #EANM2025 in Barcelona we will present results on PeptiDreams CA9-targeted peptide: 🔹 Preclinical data 🔹 First-in-human imaging data A milestone in peptide-based theranostics. #Radiopharma #Theranostics #CA9 #PDRPharma #PeptiDream"
X Link @MasatoMurakami5 2025-10-02T21:10Z XX followers, XXX engagements

"🎯 Presentations from PeptiDream / PDRadiopharma at #EANM2025 in Barcelona successfully concluded We shared results from our CA9-targeted theranostic peptide program including first-in-human imaging data. Proud of our team and this exciting step forward in nuclear medicine"
X Link @MasatoMurakami5 2025-10-06T04:21Z XX followers, XXX engagements

creator/x::MasatoMurakami5
/creator/x::MasatoMurakami5